Skip to main content

Articles

Page 37 of 39

  1. We report a case of a 48-year-old Chinese female with end-stage renal disease and chronic anemia on hemodialysis. Clonazepam was prescribed for myoclonus disorder two weeks prior to her hospitalization. Subseq...

    Authors: Marnelli A Bautista-Quach, Yu-Min Liao and Chung-Tsen Hsueh
    Citation: Journal of Hematology & Oncology 2010 3:24
    Content type: Case report Published on:

  2. Management of localized primary gastric B lymphoma (PGL) remains controversial. The aim of this study is to compare two treatments: chemotherapy alone and surgery plus chemotherapy.

    Authors: Yassir Sbitti, Nabil Ismaili, Youssef Bensouda, Habiba Kadiri, Mohammed Ichou and Hassan Errihani
    Citation: Journal of Hematology & Oncology 2010 3:23
    Content type: Short report Published on:

  3. With conventional radiation technique alone, it is difficult to deliver radical treatment (≥ 60 Gy) to gliomas that are close to critical structures without incurring the risk of late radiation induced complic...

    Authors: Eric Oermann, Brian T Collins, Kelly T Erickson, Xia Yu, Sue Lei, Simeng Suy, Heather N Hanscom, Joy Kim, Hyeon U Park, Andrew Eldabh, Christopher Kalhorn, Kevin McGrail, Deepa Subramaniam, Walter C Jean and Sean P Collins
    Citation: Journal of Hematology & Oncology 2010 3:22
    Content type: Research Published on:

  4. There has been little literature about leukemia epidemiology in Nanjing in recent years. We aimed to explore the incidence rate, gender and age distribution of leukemia in Nanjing using the leukemia database o...

    Authors: Bao-An Chen, Zhi-Hu Huang, Xiao-Ping Zhang, Jian Ou-Yang, Jian-Yong Li, Yong-Ping Zhai, Xue-Mei Sun, Yan-Li Xu, Qin Lu, Jian-Min Wang, Dong Li, Hui Liao, Zhi-Xiang Shen, Yan-Yan Wang, Xiao-Jing Yu, Hui Ye…
    Citation: Journal of Hematology & Oncology 2010 3:21
    Content type: Letter to the Editor Published on:

  5. A 24-year-old female patient was diagnosed with classic Hodgkin's lymphoma in clinical stage II, and combination chemotherapy followed by radiotherapy was initiated. During the following 5 years, the disease p...

    Authors: Inga Mandac and Slobodanka Ostojic Kolonic
    Citation: Journal of Hematology & Oncology 2010 3:20
    Content type: Letter to the Editor Published on:

  7. We have reviewed the pivotal presentations in non-small cell lung cancer (NSCLC) from the 2009 annual meeting of the American Society of Clinical Oncology. We have discussed the scientific data, the impact on ...

    Authors: Hamid R Mirshahidi and Chung T Hsueh
    Citation: Journal of Hematology & Oncology 2010 3:18
    Content type: Review Published on:

  9. Treatment options for patients with lower risk non-del(5q) myelodysplastic syndromes (MDS) who fail erythroid stimulating agents are restricted to one of the hypomethylating drugs with an expected response rat...

    Authors: Fahd Quddus, Jessica Clima, Helen Seedham, Ghulam Sajjad, Naomi Galili and Azra Raza
    Citation: Journal of Hematology & Oncology 2010 3:16
    Content type: Case report Published on:

  10. CD7 is a negative prognostic marker in myeloid malignancies. In acute myeloid leukemia (AML), an inverse correlation exists between expression of wild-type CEBPA and CD7. Aim of this study was to find out whether...

    Authors: Sonja Röhrs, Michaela Scherr, Julia Romani, Margarete Zaborski, Hans G Drexler and Hilmar Quentmeier
    Citation: Journal of Hematology & Oncology 2010 3:15
    Content type: Research Published on:

  11. The development of Philadelphia chromosome (Ph) negative acute leukemia/myelodysplastic syndrome (MDS) in patients with Ph-positive chronic myeloid leukemia (CML) is very rare. The features of restrictive usag...

    Authors: Liang Wang, Kanger Zhu, Xianfeng Zha, Shaohua Chen, Lijian Yang, Si Chen and Yangqiu Li
    Citation: Journal of Hematology & Oncology 2010 3:14
    Content type: Research Published on:

  12. Multiple myeloma (MM) is the second most common hematological malignancy in adults. It is characterized by clonal proliferation of terminally differentiated B lymphocytes and over-production of monoclonal immu...

    Authors: Johann Micallef, Moyez Dharsee, Jian Chen, Suzanne Ackloo, Ken Evans, Luqui Qiu and Hong Chang
    Citation: Journal of Hematology & Oncology 2010 3:13
    Content type: Review Published on:

  13. Oxaliplatin is a platinum compound used in the treatment of gastrointestinal malignancies, including colorectal cancer. The incidence of hypersensitivity reaction in patients receiving oxaliplatin is approxima...

    Authors: Marnelli A Bautista, W Tait Stevens, Chien-Shing Chen, Brian R Curtis, Richard H Aster and Chung-Tsen Hsueh
    Citation: Journal of Hematology & Oncology 2010 3:12
    Content type: Case report Published on:

  14. We have reviewed the pivotal presentations related to gastrointestinal malignancies from 2009 annual meeting of the American Society of Clinical Oncology with the theme of "personalizing cancer care". We have ...

    Authors: Milind Javle and Chung-Tsen Hsueh
    Citation: Journal of Hematology & Oncology 2010 3:11
    Content type: Review Published on:

  15. The ribonucleotide reductase M1 (RRM1) gene encodes the regulatory subunit of ribonucleotide reductase, the molecular target of gemcitabine. The overexpression of RRM1 mRNA in tumor tissues is reported to be a...

    Authors: Song Dong, Ai-Lin Guo, Zhi-Hong Chen, Zhen Wang, Xu-Chao Zhang, Ying Huang, Zhi Xie, Hong-Hong Yan, Hua Cheng and Yi-Long Wu
    Citation: Journal of Hematology & Oncology 2010 3:10
    Content type: Research Published on:

  16. Canfosfamide is a novel glutathione analog activated by glutathione S-transferase P1-1. This study evaluated the safety and efficacy of canfosfamide in combination with pegylated liposomal doxorubicin (PLD) in...

    Authors: John J Kavanagh, Charles F Levenback, Pedro T Ramirez, Judith L Wolf, Carla L Moore, Marsha R Jones, Lisa Meng, Gail L Brown and Robert C Bast Jr
    Citation: Journal of Hematology & Oncology 2010 3:9
    Content type: Research Published on:

  18. Due to the low survival rates from invasive ovarian cancer, new effective treatment modalities are urgently needed. Compelling evidence indicates that the immune response against ovarian cancer may play an imp...

    Authors: Bei Liu, John Nash, Carolyn Runowicz, Helen Swede, Richard Stevens and Zihai Li
    Citation: Journal of Hematology & Oncology 2010 3:7
    Content type: Review Published on:

  19. To report serial 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) tumor response following CyberKnife radiosurgery for stage IA non-small cell lung cancer (NSCLC).

    Authors: Saloomeh Vahdat, Eric K Oermann, Sean P Collins, Xia Yu, Malak Abedalthagafi, Pedro DeBrito, Simeng Suy, Shadi Yousefi, Constanza J Gutierrez, Thomas Chang, Filip Banovac, Eric D Anderson, Giuseppe Esposito and Brian T Collins
    Citation: Journal of Hematology & Oncology 2010 3:6
    Content type: Research Published on:

  20. Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and activities of transcriptional factors involved in both cancer initiation and progression through alteration of either DNA or t...

    Authors: Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo and Delong Liu
    Citation: Journal of Hematology & Oncology 2010 3:5
    Content type: Review Published on:

  21. No standard has been established for salvage therapy in gemcitabine refractory advanced urothelial cancer. We report the complete response to FOLFOX4 therapy of a metastatic urothelial cancer patient, for whom...

    Authors: Yu Ri Seo, Se Hyung Kim, Hyun Jung Kim, Chan Kyu Kim, Seong Kyu Park, Eun Suk Koh and Dae Sik Hong
    Citation: Journal of Hematology & Oncology 2010 3:4
    Content type: Case report Published on:

  23. Leser-Trélat syndrome is characterized by the eruptive appearance of multiple seborrheic keratoses in association with underlying malignant disease. Usually, the sign of Leser-Trélat is associated with adenoca...

    Authors: Giovanni Ponti, Gabriele Luppi, Lorena Losi, Alberto Giannetti and Stefania Seidenari
    Citation: Journal of Hematology & Oncology 2010 3:2
    Content type: Case report Published on:

  24. Thalidomide based regimen is an effective and well tolerated therapy in multiple myeloma (MM) patients, however, there were a small number of studies written about the results of thalidomide therapy in non-tra...

    Authors: Pimjai Niparuck, Ladda Sorakhunpipitkul, Vichai Atichartakarn, Suporn Chuncharunee, Artit Ungkanont, Pantep Aungchaisuksiri, Teeraya Puavilai and Saengsuree Jootar
    Citation: Journal of Hematology & Oncology 2010 3:1
    Content type: Letter to the Editor Published on:

  25. We have described a severe combined immunodeficiency (SCID) mouse model that permits the subcutaneous growth of primary human acute leukemia blast cells into a measurable subcutaneous nodule which may be follo...

    Authors: Ying Yan, Eric A Wieman, Xiuqin Guan, Ann A Jakubowski, Peter G Steinherz and Richard J O'Reilly
    Citation: Journal of Hematology & Oncology 2009 2:51
    Content type: Research Published on:

  26. The last two decades have witnessed striking advances in our understanding of the biological factors underlying the development of Follicular lymphoma (FL). Development of newer treatment approaches have impro...

    Authors: Nishant Tageja, Subhash Padheye, Prasad Dandawate, Ayad Al-Katib and Ramzi M Mohammad
    Citation: Journal of Hematology & Oncology 2009 2:50
    Content type: Review Published on:

  27. The International Prognostic Index (IPI) is used to determine prognosis in diffuse large B-cell lymphoma (DLBCL). One of the determinants of IPI is the stage of disease with bone marrow involvement being class...

    Authors: Dipti Talaulikar, Bruce Shadbolt, Jane E Dahlstrom and Anne McDonald
    Citation: Journal of Hematology & Oncology 2009 2:49
    Content type: Research Published on:

  28. Pulmonary involvement and skin involvement are rare complications of plasma cell neoplasms. Here we describe what may be the first reported case of a patient with relapse in both of these sites following autol...

    Authors: Yuan Yuan, Rosemary Wieczorek, David L Green, Perry Cook, Harold Ballard and David J Araten
    Citation: Journal of Hematology & Oncology 2009 2:48
    Content type: Letter to the Editor Published on:

  29. Plasmablastic lymphoma (PL) is a subtype of diffuse large B-cell lymphoma (DLBCL). Studies have suggested that tumors with PL morphology represent a group of neoplasms with clinopathologic characteristics corr...

    Authors: Chung-Che Chang, Xiaobo Zhou, Jesalyn J Taylor, Wan-Ting Huang, Xianwen Ren, Federico Monzon, Yongdong Feng, Pulivarthi H Rao, Xin-Yan Lu, Facchetti Fabio, Susan Hilsenbeck, Chad J Creighton, Elaine S Jaffe and Ching-Ching Lau
    Citation: Journal of Hematology & Oncology 2009 2:47
    Content type: Short report Published on:

  30. Tyrosine kinase inhibitors (TKIs) like dasatinib and nilotinib are indicated as second-line treatment for chronic myeloid leukemia resistant or intolerant to the current first-line TKI imatinib. These are agen...

    Authors: David Masiello, Gerry Gorospe III and Allen S Yang
    Citation: Journal of Hematology & Oncology 2009 2:46
    Content type: Review Published on:

  32. Recent studies have suggested that the presence of iron overload prior to stem cell transplantation is associated with decreased survival. Within these studies, the criteria used to define iron overload have v...

    Authors: Jonathan A Storey, Rebecca F Connor, Zachary T Lewis, David Hurd, Gregory Pomper, Yi K Keung, Manisha Grover, James Lovato, Suzy V Torti, Frank M Torti and István Molnár
    Citation: Journal of Hematology & Oncology 2009 2:44
    Content type: Research Published on:

  33. Activated Protein C [APC] improves outcome in immunocompetent patients with severe sepsis particularly in those who are perceived to have high mortality risk. Before embarking on a trial of APC administration ...

    Authors: Rakshit Panwar, Bala Venkatesh, Peter Kruger, Robert Bird, Devinder Gill, Leo Nunnink and Goce Dimeski
    Citation: Journal of Hematology & Oncology 2009 2:43
    Content type: Research Published on:

  34. The occurrence of chronic myeloid leukemia in pregnancy is rare and its management poses a clinical challenge for physicians treating these patients. We report a 30-year-old woman with chronic myeloid leukemia...

    Authors: Monika Conchon, Sabri S Sanabani, Israel Bendit, Fernanda Maria Santos, Mariana Serpa and Pedro Enrique Dorliac-Llacer
    Citation: Journal of Hematology & Oncology 2009 2:42
    Content type: Case report Published on:

  36. Hereditary spherocytosis (HS) is a genetic disorder of the red blood cell membrane clinically characterized by anemia, jaundice and splenomegaly. Evans' syndrome is a clinical syndrome characterized by autoimm...

    Authors: Hideki Yoshida, Hiroyuki Ishida, Takao Yoshihara, Takashi Oyamada, Masataka Kuwana, Toshihiko Imamura and Akira Morimoto
    Citation: Journal of Hematology & Oncology 2009 2:40
    Content type: Case report Published on:

  37. Lymphomatoid granulomatosis (LG) is a rare, Epstein-Barr virus (EBV)-associated systemic angiodestructive lymphoproliferative disorder that may progress to a diffuse large B cell lymphoma. Pulmonary involvemen...

    Authors: Ashima Makol, Kalyan Kosuri, Deimante Tamkus, Wanderley de M Calaca and Howard T Chang
    Citation: Journal of Hematology & Oncology 2009 2:39
    Content type: Case report Published on:

  38. Garcinol, harvested from Garcinia indica, has traditionally been used in tropical regions and appreciated for centuries; however its biological properties are only beginning to be elucidated. There is ample data ...

    Authors: Subhash Padhye, Aamir Ahmad, Nikhil Oswal and Fazlul H Sarkar
    Citation: Journal of Hematology & Oncology 2009 2:38
    Content type: Review Published on:

  39. The general enhanced expression of α1-antichymotrypsin (ACT), clusterin (CLU), α1-antitrypsin (AAT), haptoglobin β-chain (HAP), and leucine rich glycoprotein (LRG) in the sera of patients with epithelial ovarian ...

    Authors: Yeng Chen, Boon-Kiong Lim and Onn H Hashim
    Citation: Journal of Hematology & Oncology 2009 2:37
    Content type: Research Published on:

  40. Immunomodulatory drugs lenalidomide and pomalidomide are synthetic compounds derived by modifying the chemical structure of thalidomide to improve its potency and reduce its side effects. Lenalidomide is a 4-a...

    Authors: Venumadhav Kotla, Swati Goel, Sangeeta Nischal, Christoph Heuck, Kumar Vivek, Bhaskar Das and Amit Verma
    Citation: Journal of Hematology & Oncology 2009 2:36
    Content type: Review Published on:

  41. The complete pathological response after primary chemotherapy could represent an important prognostic factor in patients affected by colorectal liver metastases.

    Authors: Norma Malavasi, Giovanni Ponti, Roberta Depenni, Federica Bertolini, Sandra Zironi, Gabriele Luppi and Pier Franco Conte
    Citation: Journal of Hematology & Oncology 2009 2:35
    Content type: Case report Published on:

  42. Ex vivo activation and expansion of lymphocytes for adoptive cell therapy has demonstrated great success. To improve safety and therapeutic efficacy, increased antigen specificity and reduced non-specific respons...

    Authors: Shuhong Han, Yuju Huang, Yin Liang, Yuchin Ho, Yichen Wang and Lung-Ji Chang
    Citation: Journal of Hematology & Oncology 2009 2:34
    Content type: Research Published on:

  44. The response to remission induction in elderly patients with acute myeloid leukemia (AML) remains poor. The purpose of this paper is to evaluate the efficacy and toxicity of a plant alkaloid, homoharringtonine...

    Authors: Jianmin Wang, Shuqing Lü, Jianmin Yang, Xianmin Song, Li Chen, Chongmei Huang, Jun Hou and Weiping Zhang
    Citation: Journal of Hematology & Oncology 2009 2:32
    Content type: Short report Published on:

  45. Vorinostat (Zolinza®), a histone deacetylase inhibitor, was approved by the US Food and Drug Administration in October 2006 for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma...

    Authors: David Siegel, Mohamad Hussein, Chandra Belani, Francisco Robert, Evanthia Galanis, Victoria M Richon, José Garcia-Vargas, Cesar Sanz-Rodriguez and Syed Rizvi
    Citation: Journal of Hematology & Oncology 2009 2:31
    Content type: Review Published on:

  46. In the last decade the importance of ethnicity, socio-economic and gender differences in relation to disease incidence, diagnosis, and prognosis has been realized. Differences in these areas have become a majo...

    Authors: Justin P Lee, Elliott Birnstein, David Masiello, Dongyun Yang and Allen S Yang
    Citation: Journal of Hematology & Oncology 2009 2:30
    Content type: Research Published on:

  47. Advances in the treatment of chronic lymphocytic leukemia (CLL) have improved initial overall response (OR) rates, complete response (CR) rates and progression free survival (PFS). Despite these advances, CLL ...

    Authors: Kami J Maddocks and Thomas S Lin
    Citation: Journal of Hematology & Oncology 2009 2:29
    Content type: Review Published on:

  48. RIZ1 expression and activity are reduced in many cancers. In AML cell lines and patient material, RIZ1 expression is reduced relative to normal bone marrow. In chronic myelogenous leukemia (CML), blastic trans...

    Authors: Ashakumary Lakshmikuttyamma, Naoto Takahashi, Elodie Pastural, Emina Torlakovic, Hesham M Amin, Guillermo Garcia-Manero, Michael Voralia, Magdalena Czader, John F DeCoteau and C Ronald Geyer
    Citation: Journal of Hematology & Oncology 2009 2:28
    Content type: Short report Published on:

  49. Rheumatoid arthritis (RA) is an autoimmune disease mediated by inflammatory processes mainly at the joints. Recently, awareness of Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder (T-LPD...

    Authors: Michihide Tokuhira, Kyoko Hanzawa, Reiko Watanabe, Yasunobu Sekiguchi, Tomoe Nemoto, Yasuo Toyozumi, Jun-ichi Tamaru, Shinji Itoyama, Katsuya Suzuki, Hideto Kameda, Shigehisa Mori and Masahiro Kizaki
    Citation: Journal of Hematology & Oncology 2009 2:27
    Content type: Case report Published on:
JHO logo
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    28.5 - 2-year Impact Factor
    23.1 - 5-year Impact Factor
    4.045 - SNIP (Source Normalized Impact per Paper)
    6.046 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    59 days submission to accept (Median)

    2023 Usage 
    3,173,795 downloads
    2,671 Altmetric mentions

On the blog

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here. 

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us